The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The proliferation rate paradox in antimitotic chemotherapy
Open accessAbstract
Cytotoxic cancer chemotherapy drugs are believed to gain selectivity by targeting cells that proliferate rapidly. However, the proliferation rate is low in many chemosensitive human cancers, and it is not clear how a drug that only kills dividing cells could promote tumor regression. Four potential solutions to this “proliferation rate paradox” are discussed for the microtubule-stabilizing drug paclitaxel: drug retention in tumors, killing of quiescent cells, targeting of noncancer cells in the tumor, and bystander effects. Testing these potential mechanisms of drug action will facilitate rational improvement of antimitotic chemotherapy and perhaps cytotoxic chemotherapy more generally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“, 2006) and this triggers cytokine release and immune clearance (Xue et al., 2007).”
BackgroundWeinberg, R. A., & Weinberg, R. A. (2006) · W.W. Norton eBooks · doi:10.1201/9780203852569 · Cited by 1,751
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
Self-citationHMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437 · cited 1×
“Necrotic cell death caused release of the proinflammatory chromatin molecule HMGB1 (Andersson and Tracey, 2011).”
BackgroundGoodman and Gilman's The Pharmacological Basis of Therapeutics.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-453_1 · Cited by 1,011
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832 · cited 5×
“The question is, does this perturbation kill them? Cancer cells in culture exposed to paclitaxel at therapeutically relevant concentrations rarely die unless they enter mitosis (Baguley et al., 1995; Gascoigne and Taylor, 2008), but perhaps quiescent cells are more sensitive in tumors? Some aspects of the tumor enviro…”
BackgroundInfluentialRadiation-induced bystander signalling in cancer therapy
Prise, K. M., & O'Sullivan, J. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2603 · Cited by 810
Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Chonghaile, T. N., Sarosiek, K. A., Vo, T.-T., Ryan, J. A., Tammareddi, A., Moore, V. D. G., Deng, J., Anderson, K. C., Richardson, P., Tai, Y.-T., et al. (2011) · Science · doi:10.1126/science.1206727 · Cited by 585
Diagnosing and exploiting cancer's addiction to blocks in apoptosis
Letai, A. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2297 · Cited by 580
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Brown, G. C., & Neher, J. J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8105-9 · Cited by 528
Deng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., & Letai, A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.001 · Cited by 513
Secondary necrosis: The natural outcome of the complete apoptotic program
Silva, M. T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.046 · Cited by 421
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall, M. E., & Wani, M. C. (1995) · PubMed · Cited by 376
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
Mitosis is not a key target of microtubule agents in patient tumors
Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 314 · cited 7×
“This would explain the activity of microtubule-targeting drugs and lack of activity of mitosis-specific drugs in human tumors (Komlodi-Pasztor et al., 2011).”
BackgroundInfluentialDemaria, S., Volm, M., Shapiro, R. L., Yee, H. T., Oratz, R., Formenti, S. C., Muggia, F. M., & Symmans, W. F. (2001) · PubMed · Cited by 303
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
Kepp, O., Galluzzi, L., Martins, I., Schlemmer, F., Adjemian, S., Michaud, M., Sukkurwala, A. Q., Menger, L., Zitvogel, L., & Kroemer, G. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9273-4 · Cited by 297
Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel
Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W.-K., Peters, L. J., & Milas, L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.18.1308 · Cited by 286
Orth, J. D., Loewer, A., Lahav, G., & Mitchison, T. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-09-0781 · Cited by 253
Self-citationKinetics of mammary tumor cell growth and implications for therapy
Skipper, H. E. (1971) · Cancer · doi:10.1002/1097-0142(197112)28:6<1479::aid-cncr2820280622>3.0.co;2-m · Cited by 234
Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Shi, J., Orth, J. D., & Mitchison, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6699 · Cited by 234
Self-citationKanthou, C., & Tozer, G. M. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00651.x · Cited by 197
Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation
Verin, A. D., Birukova, A., Wang, P., Liu, F., Becker, P., Birukov, K., & Garcia, J. G. N. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.3.l565 · Cited by 174
Javeed, A., Ashraf, M., Riaz, A., Ghafoor, A., Afzal, S., & Mukhtar, M. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.08.009 · Cited by 172
Orth, J. D., Köhler, R. H., Foijer, F., Sorger, P. K., Weissleder, R., & Mitchison, T. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0412 · Cited by 159
Self-citationSymmans, W. F., Volm, M. D., Shapiro, R. L., Perkins, A., Kim, A. Y., Demaria, S., Yee, H. T., McMullen, H., Oratz, R., Klein, P., et al. (2000) · PubMed · Cited by 149
Navitoclax (ABT-263) Accelerates Apoptosis during Drug-Induced Mitotic Arrest by Antagonizing Bcl-xL
Shi, J., Zhou, Y., Huang, H.-C., & Mitchison, T. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4336 · Cited by 147
Self-citationAurora kinase inhibitors as anticancer molecules
Katayama, H. G., & Sen, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.09.004 · Cited by 141
Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
Skipper, H. E., & Perry, S. (1970) · PubMed · Cited by 140
Cellular radiation effects and the bystander response
Little, J. B. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.001 · Cited by 137
Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey, C. L., Perera, P., Salkowski, C. A., & Vogel, S. N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.825 · Cited by 131
Predictive factors for response to docetaxel in human breast cancers
Noguchi, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00265.x · Cited by 127
Orth, J. D., Tang, Y., Shi, J., Loy, C. T., Amendt, C., Wilm, C., Zenke, F. T., & Mitchison, T. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0684 · Cited by 127
Self-citationActivity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer
Purcell, J. W., Davis, J., Reddy, M., Martin, S., Samayoa, K., Vo, H., Thomsen, K., Bean, P., Kuo, W. L., Ziyad, S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1498 · Cited by 100
Guerriero, J. L., Ditsworth, D., Catanzaro, J. M., Sabino, G. J., Furie, M. B., Kew, R. R., Crawford, H. C., & Zong, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003267 · Cited by 97
PLK1 as an oncology target: current status and future potential
McInnes, C., & Wyatt, M. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.002 · Cited by 91
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel
Schimming, R., Mason, K. A., Hunter, N., Weil, M. M., Kishi, K., & Milas, L. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050879 · Cited by 89
Amadori, D., Volpi, A., Maltoni, R., Nanni, O., Amaducci, L., Amadori, A., Giunchi, D. C., Vio, A., Saragoni, A., & Silvestrini, R. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005780107879 · Cited by 66
Baguley, B. C., Marshall, E. S., Whittaker, J. R., Dotchin, M. C., Nixon, J., McCrystal, M. R., Finlay, G. J., Matthews, J. H. L., Holdaway, K. M., & van Zijl, P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00472-h · Cited by 62
Ribeiro, J. M., Macedo, L. T., Curigliano, G., Fumagalli, L. A. M., Locatelli, M., Dalton, M., Quintela, A., Carvalheira, J. B. C., Manunta, S., Mazzarella, L., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr382 · Cited by 49
Blagosklonny, M. V., Demidenko, Z. N., Giovino, M. A., Szynal, C., Donskoy, E., Herrmann, R. A., Barry, J. J., & Whalen, A. M. (2006) · Cell Cycle · doi:10.4161/cc.5.14.3113 · Cited by 40
Myeloid cell kinetics in response to haemopoietic growth factors
Lord, B. I. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80006-5 · Cited by 30
Rapid induction of apoptosis during Kinesin-5 inhibitor-induced mitotic arrest in HL60 cells
Tang, Y., Orth, J. D., Xie, T., & Mitchison, T. J. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.024 · Cited by 15
Self-citation
Cited by
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Singh, R., Letai, A., & Sarosiek, K. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0089-8 · Cited by 2,111
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Győrffy, B. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.014 · Cited by 1,648
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
Metadata
- Authors
- Mitchison, T. J.
- Venue
- Molecular Biology of the Cell
- Published
- 2012-01
- Volume
- 23
- Issue
- 1
- Pages
- 1-6
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W1994406643
- Cited by
- 363
- References
- 46
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.